BioMarin has made the decision to discontinue development of VOXZOGO® (vosoritide) for children with Noonan syndrome. Read the press release here.
Restoring the brake: Using molecular glues to fix a broken CRAF off-switch in Noonan Syndrome Another RAS Dialogue Blog post has dropped from the NCI Frederick National Lab RAS…
❓ What have we been working towards? ♥ Read the RAS Dialogue Blog from Marielle Yohe that encapsulates the efforts of so many people who care about and want to…
